Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

With respect to risks, GLP-1RA use was significantly associated with an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, drug-induced pancreatitis, and other ...

Several years ago, a little-known drug named Ozempic — previously used only to treat diabetes — emerged as a promising new ...

The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, according to a ...

For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduced risk for certain disorders and conditions.

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

As part of our Masterclass series, GP specialist in diabetes Dr Elizabeth Martin explains the key points in prevention, ...

By Nicole Fell Kendrick Lamar’s diss track turned chart-topping hit “Not Like Us” has hit 1 billion streams on Spotify. The critically acclaimed song, released amid an ongoing feud with ...

These findings open up new approaches for managing conditions like ... and glucagon, both produced by the pancreas. Insulin lowers blood glucose by promoting its uptake into cells, while glucagon ...

The suit stems from the diss track “Not Like Us” by Kendrick Lamar, another UMG artist. Drake’s legal complaint also again accuses UMG of using bots on Spotify and other streaming platforms ...

Jan 14 (Reuters) - Generative artificial intelligence bellwether OpenAI said on Tuesday that it is introducing a beta feature called ... sales or recurring actions like weekly news briefings ...

The data “pave the way for a potentially transformative cure,” for a disease that affects more than ... of c-peptide expression—a biomarker that indicates if the transplanted beta cells ...